Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE Study. - Chen EY; Nabavizadeh N; Kendsersky ND; Lessenich C; Herzig DO; Korngold E; Goodyear SM; Kennecke HF; Kardosh A; Tsikitis VL; Lu KC; Fang S; et al. (Clinical colorectal cancer, 2026)